As psychedelic medicine evolves, the field may need to think beyond the question of whether psychedelics can treat illness and begin asking a broader one: What role, if any, should they play in helping people who are already well live better?
Much of the research and public conversation around psilocybin has focused on its potential to treat psychiatric disorders. But what about people who are not seeking treatment for a mental illness?
This panel explores the emerging role of psilocybin in supporting wellbeing, personal growth, and psychological health outside of a traditional disease-treatment framework.
Panelists will bring perspectives from clinical practice, research, individual facilitation, and group settings to discuss:
- What we currently know about psilocybin and wellbeing in people without severe mental illness.
- How the goals, experience, and outcomes of psilocybin use may differ when the focus is wellbeing rather than treatment.
- The role of preparation, facilitation, integration, and setting when psilocybin is used to support wellbeing.
- How individual and group approaches may differ.
- The clinical, ethical, and practical questions that arise as psychedelic medicine expands beyond traditional treatment models.
As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on September 29th at 5 pm Pacific, 8 pm Eastern. A link to the recording will be available afterward if you cannot make it to the live event.
Hope to see you all on the 29th!

